Paul T Quinlan's Net Worth
$2.45 Million
Who is Paul T Quinlan?
Paul T Quinlan has an estimated net worth of $2.45 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., TerraVia Holdings, Inc., and Oruka Therapeutics, Inc..
SEC CIK
Paul T Quinlan's CIK is 0001333277
Past Insider Trading and Trends
2012 was Paul T Quinlan's most active year for acquiring shares with 14 total transactions. Paul T Quinlan's most active month to acquire stocks was the month of January. 2012 was Paul T Quinlan's most active year for disposing of shares, totalling 27 transactions. Paul T Quinlan's most active month to dispose stocks was the month of February. 2024 saw Paul T Quinlan paying a total of $344,691.36 for 180,887 shares, this is the most they've acquired in one year. In 2023 Paul T Quinlan cashed out on 176,000 shares for a total of $1,380,411.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CymaBay Therapeutics, Inc. (CBAY) No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -70.26K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +147.07% | 41.82K |
$7.89 | $329,991.36 | 70.26K |
Mar 13
| |||
Form 4
|
∞
| 28.44K |
—
|
—
| 28.44K |
Jan 24
| |||
Form 4
|
—
|
0
|
$13.26 | -$103,198.00 |
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
$12.46 | -$95,202.50 |
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$10.16 | -$72,189.00 |
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
$8.35 | -$54,098.00 |
0
|
Oct 16
| |||
Form 4
|
—
|
0
|
$9.91 | -$738,320.80 |
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
$7.43 | -$44,850.50 |
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
$7.38 | -$44,350.00 |
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
$6.50 | -$35,550.00 |
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
$6.65 | -$37,131.00 |
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TerraVia Holdings, Inc. No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.27% | -25.00K |
$0.81 | -$20,232.50 | 218.4K |
Scheduled
|
Mar 9
| ||
Form 4
| +102.16% | 123K |
—
|
—
| 243.4K |
Feb 6
| |||
Form 4
| -7.67% | -10.00K |
$2.55 | -$25,528.00 | 120.4K |
Scheduled
|
Oct 14
| ||
Form 4
| -2.34% | -3.12K |
$2.60 | -$8,127.40 | 130.53K |
Scheduled
|
Sep 16
| ||
Form 4
| -1.16% | -1.56K |
$2.74 | -$4,272.85 | 133.65K |
Scheduled
|
Sep 13
| ||
Form 4
| -3.40% | -4.69K |
$1.64 | -$7,666.30 | 133.01K |
Scheduled
|
Mar 10
| ||
Form 4
| +79.39% | 60.94K |
$1.66 | -$2,600.11 | 137.69K |
Scheduled
|
Mar 8
| ||
Form 4
| -3.91% | -3.12K |
$3.11 | -$9,725.17 | 76.75K |
Scheduled
|
Sep 15 - Sep 17
| ||
Form 4
| -10.82% | -9.69K |
$2.69 | -$26,097.75 | 79.88K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +27.38% | 19.25K |
$2.67 | -$15,344.49 | 89.57K |
Mar 2 - Mar 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| -19.06% | -16.56K |
$8.53 | -$141,237.42 | 70.31K |
Scheduled
|
Sep 9
| ||
Form 4
| -2.80% | -2.50K |
$5.89 | -$66,014.90 | 86.88K |
Scheduled
|
Aug 15 - Aug 19
| ||
Form 4
|
—
|
0
|
$6.08 | -$44,677.20 | 86.88K |
Scheduled
|
Jul 21
| ||
Form 4
|
—
|
0
|
$7.17 | -$57,862.80 | 86.88K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$5.78 | -$41,118.00 | 86.88K |
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
$6.84 | -$53,893.80 | 86.88K |
Scheduled
|
Apr 21
| ||
Form 4
|
—
|
0
|
$8.37 | -$72,255.60 | 86.88K |
Scheduled
|
Mar 19
| ||
Form 4
| -3.47% | -3.13K |
$12.21 | -$38,146.87 | 86.88K |
Scheduled
|
Mar 4
| ||
Form 4
| -2.43% | -2.24K |
$6.98 | -$81,581.98 | 90K |
Scheduled
|
Feb 24
| ||
Form 4
| +38.46% | 25K |
—
|
—
| 90K |
Feb 12
| |||
Form 4
| -8.45% | -6.00K |
$10.47 | -$62,844.60 | 65K |
Scheduled
|
Jan 21
| ||
Form 4
| -7.79% | -6.00K |
$9.40 | -$56,407.20 | 71K |
Scheduled
|
Dec 19
| ||
Form 4
| -7.23% | -6.00K |
$8.41 | -$50,458.80 | 77K |
Scheduled
|
Nov 19
| ||
Form 4
| -6.74% | -6.00K |
$11.47 | -$68,820.00 | 83K |
Scheduled
|
Oct 21
| ||
Form 4
| -6.32% | -6.00K |
$10.73 | -$64,370.40 | 89K |
Scheduled
|
Sep 19
| ||
Form 4
| -0.77% | -739.00 |
$11.89 | -$8,786.71 | 95K |
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$7.19 | -$29,079.00 | 95K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$6.76 | -$26,458.20 | 95K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$6.18 | -$160,650.00 | 95K |
Scheduled
|
May 10
| ||
Form 4
| +216.67% | 65K |
—
|
—
| 95K |
Feb 25
| |||
Form 4
|
—
|
0
|
$6.30 | -$15,787.80 | 30K |
Scheduled
|
Oct 12
| ||
Form 4
|
—
|
0
|
$6.87 | -$27,122.10 | 30K |
Scheduled
|
Sep 19
| ||
Form 4
|
—
|
0
|
$6.90 | -$18,170.60 | 30K |
Scheduled
|
Sep 12
| ||
Form 4
|
—
|
0
|
$7.76 | -$32,452.50 | 30K |
Scheduled
|
Aug 20
| ||
Form 4
|
—
|
0
|
$7.12 | -$19,074.00 | 30K |
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$7.93 | -$33,465.30 | 30K |
Scheduled
|
Jul 19
| ||
Form 4
|
—
|
0
|
$6.89 | -$18,142.00 | 30K |
Scheduled
|
Jul 12
| ||
Form 4
|
—
|
0
|
$7.29 | -$19,751.00 | 30K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$6.21 | -$15,426.00 | 30K |
Scheduled
|
May 14
| ||
Form 4
|
—
|
0
|
$7.58 | -$20,926.00 | 30K |
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
$8.16 | -$23,241.00 | 30K |
Scheduled
|
Mar 12
| ||
Form 4
| -7.69% | -2.50K |
$13.13 | -$32,835.50 | 30K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$6.83 | -$17,891.20 | 30K |
Scheduled
|
Feb 11 - Feb 13
| ||
Form 4
|
—
|
0
|
$6.76 | -$17,626.00 | 30K |
Scheduled
|
Jan 12
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oruka Therapeutics, Inc. (ABIO) Snapshot price: $2.48
General Counsel and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||